Name: SYKES & RAY EQUITIES (I) LTD.
Address: 3rd Floor, Cama Building, Dalal St, Kala Ghoda, Fort, Mumbai, 400001, IN
Telephone: 022 6193 7300

Markets

Market Nav

HALF YEARLY RESULTS

You can view the half yearly results for the last 5 years.

Vista Pharmaceuticals Ltd.

Jul 03, 04:01 BSE 10.78 (+ 0.14 1.32%)

Volume15891

Prev. Close
10.64

Open Price
10.22

Today's Low / High

10.22 11.14

Bid. Price (Qty.)0.00 (0)

Offer Price (Qty.)
0.00 (0)

52 Wk Low / High

9.10 16.59

Vista Pharmaceuticals Ltd.is not traded in NSE

Standalone

(₹ in Crs.)

Particulars	Mar 25	Sep 24	Mar 24	Sep 23	Mar 23
Net Sales/Income from operations	5.79	4.29	4.84	5.45	1.00
Total Income From Operations	5.79	4.29	4.84	5.45	1.00

EXPENDITURE
Consumption of Raw Materials	4.74	3.16	3.71	5.18	1.23
Increase/Decrease in Stocks	0.45	0.00	0.01	0.00	0.00
Employees Cost	1.08	0.93	0.93	0.86	0.50
Depreciation	0.37	0.37	0.36	0.36	1.26
Other Expenses	1.95	1.80	1.67	1.50	0.98
Total Expenses	8.58	6.26	6.68	7.90	3.98

P/L Before Other Inc. , Int., Excpt. Items & Tax	-2.80	-1.97	-1.85	-2.44	-2.97
Other Income	0.36	0.08	0.12	0.21	0.29
P/L Before Interest, Excpt. Items & Tax	-2.44	-1.89	-1.72	-2.23	-2.69
Interest	0.43	0.54	0.57	0.64	0.72
P/L Before Exceptional Items & Tax	-2.87	-2.42	-2.30	-2.88	-3.41
P/L Before Tax	-2.87	-2.42	-2.30	-2.88	-3.41
Tax	-0.05	-0.59	-0.76	0.10	1.42
P/L After Tax from Ordinary Activities	-2.82	-1.83	-1.54	-2.97	-4.83
Net Profit/Loss For the Period	-2.82	-1.83	-1.54	-2.97	-4.83

Equity Share Capital	12.31	12.31	9.43	8.84	7.36
EPS Before Extra Ordinary *
Basic EPS (Rs.)	-0.45	-0.31	-0.32	-0.72	-1.31
Diluted EPS (Rs.)	(0.46)	-0.31	(0.33)	-0.49	(1.31)
EPS After Extra Ordinary *
Basic EPS (Rs.)	-0.45	-0.31	-0.32	-0.72	-1.31
Diluted EPS (Rs.)	0.00	-0.31	0.00	-0.49	0.00

PBITOE Margin (%)	-48.39	-45.84	-38.17	-44.85	-296.37
PBTE Margin (%)	-49.54	-56.49	-47.54	-52.79	-339.53
PBT Margin (%)	-49.54	-56.49	-47.54	-52.79	-339.53
PAT Margin (%)	-48.70	-42.67	-31.79	-54.55	-480.76

Particulars	Mar 25
Months	12
Source Of Info (AR = Annual Report, PR = Press Release)	PR
FaceValue	1.00

Net Profit/Loss Before Extraordinary Items And Tax	2434.76
Net CashFlow From Operating Activities	1129.01
Net Cash Used In Investing Activities	2222.09
Net Cash Used From Financing Activities	-1882.63
Net Inc/Dec In Cash And Cash Equivalents	1468.47
Cash And Cash Equivalents Begin of Year	-1391.81
Cash And Cash Equivalents End Of Year	76.66